Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
NCT04992026Phase 2Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Time to PSA progression up to 2 years and Time to Radiographic progression up to 2 years. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04992026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992026.